Learn more about investing in Protogenix

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Protogenix
Making animal protein ingredients safely in plants
Founded
2021
Employees*
4
Funding to Date*
$525,000
Website
proto-genix.com
* Data source: Crunchbase
"The science that lies behind Protogenix provides us with innovative approaches with which to address food insecurity on many levels. Reducing our reliance on animals will lower the carbon footprint associated with conventional food production."

Protogenix is focused the production of recombinant proteins for the cost-effective production of eukaryotic, complex, biologically active glycoproteins, including functional vaccine antigens and monoclonal antibodies (mAbs) without using mammalian cells. The company believes that its proprietary systems will deliver a step change in the cost, safety and speed of production for the healthcare, veterinary and food production industries.